New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Thermo Fisher Scientific Inc.
TMO
Shape
US Flag

NYSE

234B

Medical - Diagnostics & Research

Next Earning date - 23 Oct 2024

234B

Medical - Diagnostics & Research

Next Earning date - 23 Oct 2024

612.72USD
Shape-0.22 ( -0.04%)
favorite-chart

Relative Strenght

44
favorite-chart

Volume Buzz

-63%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 3, 2024
1W -0.33 % 1M 0.15 % 3M 13.46 % 1Y 22.21 %

Key Metrics

Shape
  • Market Cap

    234.06B


  • Shares Outstanding

    382.00M


  • Share in Float

    381.39M


  • Dividende

    1.56


  • Earning Date

    23 Oct 2024


  • Price Target

    612.72


  • Average Volume

    1.35M


  • Beta

    0.778


  • Range

    415.6-627.88


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.thermofisher.com


  • Sector

    Healthcare


Fundamentals

Shape

28.04x

P/E Ratio

5.53x

P/S Ratio

4.94x

P/B Ratio

0.7

Debt/Equity

14.7%

Net Margin

$16.1

EPS

How TMO compares to sector?

P/E Ratio

Relative Strength

Shape

TMO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$46B

Shape332%

2025-Revenue

$18.37

Shape354%

2025-EPS

$13B

Shape402%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2024-09-30

Now: Overweight

Wells Fargo

initialise

Previous: Underweight

2024-08-27

Now: Overweight

Jefferies

upgrade

Previous: Not converted

2024-06-03

Now: Buy

CFRA

upgrade

Previous: Not converted

2024-03-25

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-22%

5.08
vs 6.54

Q4.22

arrow
arrow

-17%

5.4
vs 6.54

Q2.23

arrow
arrow

-31%

5.03
vs 7.25

Q3.23

arrow
arrow

-7%

5.15
vs 5.51

Q3.23

arrow
arrow

+3%

5.69
vs 5.51

Q4.23

arrow
arrow

+5%

5.67
vs 5.4

Q1.24

arrow
arrow

N/A

5.11
vs NA

Q2.24

arrow
arrow

+7%

5.37
vs 5.03

Q3.24

arrow
arrow

-8%

5.25
vs 5.69

Q4.24

arrow
arrow

+6%

5.99
vs 5.67

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

0%

10.7B  vs 10.7B

Q4.22

arrow
arrow

+7%

11.4B  vs 10.7B

Q2.23

arrow
arrow

-9%

10.7B  vs 11.8B

Q3.23

arrow
arrow

-3%

10.7B  vs 11B

Q3.23

arrow
arrow

-4%

10.6B  vs 11B

Q4.23

arrow
arrow

-5%

10.9B  vs 11.4B

Q1.24

arrow
arrow

NA

10.3B  vs NA

Q2.24

arrow
arrow

-2%

10.5B  vs 10.7B

Q3.24

arrow
arrow

+1%

10.6B  vs 10.6B

Q4.24

arrow
arrow

+4%

11.3B  vs 10.9B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+3%

0.03
vs 0.04

Q4.22

arrow
arrow

+4%

0.04
vs 0.03

Q2.23

arrow
arrow

+3%

0.03
vs 0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.03

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+3%

0.03
vs 0.03

Q2.24

arrow
arrow

+3%

0.03
vs 0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

2305

2.3K
vs 2.3K

-1%

Q4.22

arrow
arrow

2425

2.4K
vs 2.3K

5%

Q1.23

arrow
arrow

2417

2.4K
vs 2.4K

0%

Q2.23

arrow
arrow

2430

2.4K
vs 2.4K

1%

Q3.23

arrow
arrow

2404

2.4K
vs 2.4K

-1%

Q4.23

arrow
arrow

2534

2.5K
vs 2.4K

5%

Q1.24

arrow
arrow

2559

2.6K
vs 2.5K

1%

Q2.24

arrow
arrow

2529

2.5K
vs 2.6K

-1%

Earnings Growth

Latest News